CORRESP Filing
ADC Therapeutics SA
Date: March 12, 2026 · CIK: 0001771910 · Accession: 0000950103-26-003667
AI Filing Summary & Sentiment
File numbers found in text: 333-294191
Show Raw Text
CORRESP 1 filename1.htm March 12, 2026 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: ADC Therapeutics SA Registration Statement on Form S-3 Registration No. 333-294191 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-294191) (the "Registration Statement") of ADC Therapeutics SA. We respectfully request that the Registration Statement be declared effective as of 4:00 p.m., Eastern time, on March 16, 2026, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling David Li at (212) 450-3861. Thank you for your assistance in this matter. Sincerely, ADC Therapeutics SA By: /s/ Peter J. Graham Name: Peter J. Graham Title: Chief Legal Officer